Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2019 | 11-2018 | 11-2017 | 11-2006 | |
| Sales | 31,115 | 37,449 | 0 | 0 |
| Gross Profit | 31,115 | 37,449 | N/A | N/A |
| Operating Expenses | 53,351 | 47,188 | 0 | 0 |
| Operating Income | -22,236 | -9,739 | N/A | N/A |
| Other Income | 776 | 818 | 0 | 0 |
| Pre-tax Income | -21,460 | -8,921 | 0 | 0 |
| Income Tax | 239 | 507 | N/A | N/A |
| Net Income Continuous | -21,699 | -9,428 | N/A | N/A |
| Net Income | $-21,699 | $-9,428 | $N/A | $N/A |
| EPS Basic Total Ops | -6.59 | -3.35 | N/A | N/A |
| EPS Basic Continuous Ops | -6.59 | -3.35 | N/A | N/A |
| EPS Diluted Total Ops | -6.59 | -3.35 | N/A | N/A |
| EPS Diluted Continuous Ops | -6.59 | -3.35 | N/A | N/A |
| EBITDA(a) | $-19,991 | $-7,105 | $N/A | $N/A |